IP Library Assignment 041033/0327
Patent Assignment
Reel/Frame 041033/0327

Assignment of Assignor's Interest

Recorded: 2016-12-20 Pages: 15
Assignor
AXOVANT SCIENCES LTD.
Executed: 2016-12-13
Assignee
AXOVANT SCIENCES GMBH
C/O VISCHER AG, AESCHENVORSTADT 4, BASEL, CH-4010, SWITZERLAND
Covered Properties (49)
Quinoline Derivatives and Their Use as 5-HT6 Ligands
Patent: 7,452,888 →
Application: 10/509,078 →
Publication: US 2005/0124628
Quinoline Derivatives and Their Use as 5-HT6 Ligands
Patent: 7,601,837 →
Application: 12/205,079 →
Publication: US 2009/0036682
Quinoline Derivatives and Their Use as 5-HT6 Ligands
Patent: 7,799,774 →
Application: 12/541,456 →
Publication: US 2009/0298841
Quinoline Derivatives and Their Use as 5-HT6 Ligands
Patent: 7,977,337 →
Application: 12/847,039 →
Publication: US 2010/0305107
Quinoline Derivatives and Their Use as 5-HT6 Ligands
Patent: 8,236,947 →
Application: 13/152,356 →
Publication: US 2011/0237792
Polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline
Application: 10/572,670 →
Publication: US 2007/0032504
Radiolabelled Quinoline-Based Ligands for the 5-HT6 Receptor Functionality
Application: 11/719,808 →
Novel Chemical Process For the Synthesis of Quinoline Compounds
Application: 12/067,537 →
Publication: US 2008/0255359
Use of Quinoline Derivatives in the Treatment of Pain and Irritable Bowel Syndrome
Application: 12/531,896 →
Publication: US 2010/0041672
Combinations Comprising 3-Phenylsulfonyl-8-Piperazinyl-1YL-Quinoline
Patent: 9,084,742 →
Application: 12/746,968 →
Publication: US 2010/0267691
Combinations Comprising 3-Phenylsulfonyl-8-Piperazinyl-1YL-Quinoline
Patent: 9,808,455 →
Application: 14/802,036 →
Publication: US 2015/0320742
Methods of Treating a Neurodegenerative Disease
Application: 62/162,068 →
Methods of Treating a Neurodegenerative Disease
Application: 15/149,040 →
Publication: US 2016/0324851
Methods of Treating a Neurodegenerative Disease with 3-Phenylsulfonyl-8-Piperazinyl-1YL-Quinoline and Lithium
Application: 62/162,060 →
Methods of Dosing 3-Phenylsulfonyl-8-Piperazinyl-1YL-Quinoline to Treat a Neurodegenerative Disease
Application: 62/162,138 →
Methods of Treating a Neurodegenerative Disease
Application: 62/162,193 →
Compositions and Methods of Treating a Neurodegenerative Disease
Application: 15/149,053 →
Publication: US 2016/0324852
Methods of Treating a Neurodegenerative Disease
Application: 62/168,246 →
Methods of Treating a Neurodegenerative Disease
Application: 62/169,414 →
Methods of Treating a Neurodegenerative Disease
Application: 62/182,225 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/158,422 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/165,034 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/167,986 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/189,089 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/191,189 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/201,513 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/239,530 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/251,534 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/256,349 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/261,115 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/289,643 →
Compositions and Methods for Treating Alzheimer's Disease
Application: 62/289,162 →
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder
Application: 62/174,983 →
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder
Application: 15/179,926 →
Publication: US 2016/0361296
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder
Application: 62/194,084 →
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder
Application: 62/236,562 →
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder
Application: 62/263,967 →
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder
Application: 62/278,198 →
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Dementia with Lewy Bodies
Application: 62/192,939 →
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Hallucinations Associated with a Neurodegenerative Disease
Application: 15/211,638 →
Publication: US 2017/0014385
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Visual Hallucinations Associated with Lewy Body Dementia
Application: 62/236,618 →
Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Visual Hallucinations Associated with Lewy Body Dementia
Application: 62/261,381 →
Methods of Reducing Falls in Patients with Parkinson's Disease Dementia
Application: 62/299,725 →
Methods of Reducing Falls in Patients with Parkinson's Disease Dementia
Application: 62/406,821 →
Compositions and Methods of Treating a Neurodegenerative Disease
Application: 62/375,355 →
Methods of Treating a Neurodegenerative Disease
Compositions and Methods of Treating a Neurodegenerative Disease
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Rem Sleep Behavior Disorder
Diaryl and Arylheteroaryl Urea Derivatives as Modulators of the 5-HT2A Serotonin Receptor Useful for the Prophylaxis and Treatment of Hallucinations Associated with a Neurodegenerative Disease
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 1, 2005
From: AHMED, MAHMOOD; JOHNSON, CHRISTOPHER NORBERT; JONES, MARTIN C.; MACDONALD, GREGOR JAMES
To: GLAXO GROUP LIMITED
Reel/Frame 016295/0382 →
Assignment of Assignor's Interest Jun 12, 2007
From: GEE, ANTONY DAVID; JOHNSON, CHRISTOPHER NORBERT; MARTARELLO, LAURENT; WITTY, DAVID R
To: GLAXO GROUP LIMITED
Reel/Frame 019415/0243 →
Assignment of Assignor's Interest Feb 18, 2008
From: GLADWIN, ASA ELIZABETH
To: GLAXO GROUP LIMITED
Reel/Frame 020521/0187 →
Assignment of Assignor's Interest Mar 24, 2008
From: WADE, CHARLES EDWARD
To: GLAXO GROUP LIMITED
Reel/Frame 020689/0946 →
Assignment of Assignor's Interest Sep 18, 2009
From: BRUTON, GORDON; STEMP, GEOFFREY; ORLEK, BARRY SIDNEY
To: GLAXO GROUP LIMITED
Reel/Frame 023251/0399 →
Assignment of Assignor's Interest Jun 9, 2010
From: CHUANG, TSU TSHEN; HUNTER, ANN JACQUELINE; VIRLEY, DAVID JOHN
To: GLAXO GROUP LIMITED
Reel/Frame 024507/0440 →
Assignment of Assignor's Interest Feb 5, 2015
From: GLAXO GROUP LIMITED
To: ROIVANT NEUROSCIENCES LTD.
Reel/Frame 034898/0900 →
Change of Name Apr 17, 2015
From: ROIVANT NEUROSCIENCES LTD.
To: AXOVANT SCIENCES LTD.
Reel/Frame 035455/0330 →
Assignment of Assignor's Interest Jul 21, 2015
From: FRIEDHOFF, LAWRENCE TIM
To: AXOVANT SCIENCES LTD.
Reel/Frame 036145/0948 →
Assignment of Assignor's Interest Jul 21, 2015
From: FRIEDHOFF, LAWRENCE TIM
To: AXOVANT SCIENCES LTD.
Reel/Frame 036140/0747 →
Change of Name Sep 10, 2015
From: ROIVANT NEUROSCIENCES LTD.
To: AXOVANT SCIENCES LTD.
Reel/Frame 036537/0331 →
Assignment of Assignor's Interest Sep 10, 2015
From: FRIEDHOFF, LAWRENCE TIM
To: AXOVANT SCIENCES LTD.
Reel/Frame 036537/0375 →
Assignment of Assignor's Interest Sep 10, 2015
From: CHUANG, TSU TSHEN; VIRLEY, DAVID JOHN; HUNTER, ANN JACQUELINE
To: GLAXO GROUP LIMITED
Reel/Frame 036537/0296 →
Assignment of Assignor's Interest Sep 10, 2015
From: GLAXO GROUP LIMITED
To: ROIVANT NEUROSCIENCES LTD.
Reel/Frame 036537/0311 →
Assignment of Assignor's Interest May 11, 2016
From: FRIEDHOFF, LAWRENCE TIM; PISCITELLI, STEPHEN CLEMENT; LOMBARDO, ILISE; RAMASWAMY, GEETHA
To: AXOVANT SCIENCES LTD.
Reel/Frame 038551/0551 →
Assignment of Assignor's Interest May 11, 2016
From: FRIEDHOFF, LAWRENCE TIM; PISCITELLI, STEPHEN CLEMENT
To: AXOVANT SCIENCES LTD.
Reel/Frame 038551/0661 →
Assignment of Assignor's Interest May 11, 2016
From: FRIEDHOFF, LAWRENCE TIM; PISCITELLI, STEPHEN CLEMENT; LOMBARDO, ILISE
To: AXOVANT SCIENCES LTD.
Reel/Frame 038551/0617 →
Assignment of Assignor's Interest May 11, 2016
From: FRIEDHOFF, LAWRENCE TIM; PISCITELLI, STEPHEN CLEMENT; LOMBARDO, ILISE; RAMASWAMY, SHANKAR
To: AXOVANT SCIENCES LTD.
Reel/Frame 038682/0320 →
Assignment of Assignor's Interest May 12, 2016
From: FRIEDHOFF, LAWRENCE TIM
To: AXOVANT SCIENCES LTD.
Reel/Frame 038691/0468 →
Assignment of Assignor's Interest May 12, 2016
From: FRIEDHOFF, LAWRENCE TIM; PISCITELLI, STEPHEN CLEMENT
To: AXOVANT SCIENCES LTD.
Reel/Frame 038567/0649 →
Assignment of Assignor's Interest May 12, 2016
From: FRIEDHOFF, LAWRENCE TIM
To: AXOVANT SCIENCES LTD.
Reel/Frame 038565/0013 →
Assignment of Assignor's Interest Aug 30, 2016
From: RHODES, MELISSA
To: AXOVANT SCIENCES LTD.
Reel/Frame 039577/0799 →
Assignment of Assignor's Interest Aug 30, 2016
From: FRIEDHOFF, LAWRENCE TIM
To: AXOVANT SCIENCES LTD.
Reel/Frame 039574/0869 →
Assignment of Assignor's Interest Aug 30, 2016
From: PISCITELLI, STEPHEN CLEMENT
To: AXOVANT SCIENCES LTD.
Reel/Frame 039574/0909 →
Assignment of Assignor's Interest Aug 30, 2016
From: KISHNANI, KUNAL
To: AXOVANT SCIENCES LTD.
Reel/Frame 039574/0968 →